Pumpkin Seed Oil Supplementation in Premenopausal Women

June 17, 2015 updated by: Texas Woman's University

The Effect of Pumpkin Seed Oil Supplementation on Blood Pressure in Premenopausal Women

The purpose of this study is to determine whether or not there is an effect of pumpkin seed oil supplementation, 2 grams per day, on blood pressure (systolic and diastolic) in premenopausal women.

Study Overview

Detailed Description

The research study will be conducted over a 12-week period. Overall, each participant will meet with the researcher three times. During the first visit, after the participant has signed the consent form, their blood pressure will be taken with a digital blood pressure monitor. If her systolic blood pressure is greater than 140 mmHg or her diastolic blood pressure is greater than 90 mmHg, she will not be eligible to take part in this study. If the participant is able to take part in this study, she will be given a code number to protect confidentiality and randomly assigned to one of two groups, Group I or Group II. The participant will then be asked to state their age, ethnicity, menopausal status, and whether or not they are taking oral contraceptives. Next, height and weight will be taken with an instrument called a Health-O-Meter. Body mass index (BMI) and percent body fat will be calculated using an instrument called a Body Composition Analyzer. After all measurements are taken, participants will be given instructions on how to keep a 3-day diet and supplement diary. A booklet will be provided to help them record their diet for two nonconsecutive week days and one weekend day. The 3-day diet and supplement diary is to be completed during the week between the first and second session with the researcher. During this session the participant will be asked to complete a food frequency questionnaire to help the researcher asses the phytoestrogen content of her diet. At the end of the first session, the researcher will schedule a second session with the participant.

The second session will take place one week after the first session. During the second session, measurements taken will be height, weight, BMI, percent body fat, and blood pressure. Participants will be asked to return the 3-day diet and supplement diary to the researcher. The researcher will review the diary and ask questions to clarify foods recorded. The participant will then be asked to complete a physical activity questionnaire. Next, supplements will be distributed. The participants will not have knowledge of which group they are assigned to. Group I will receive 168 capsules, each capsule containing 1 gram of wheat germ oil, in two pill bottles. One bottle will contain 100 capsules; the second bottle will contain 68 capsules. Group II will receive 168 capsules, each capsule containing 1 gram of pumpkin seed oil, in two pill bottles. One bottle will contain 100 capsules; the second bottle will contain 68 capsules. Participants will be instructed to take 2 capsules per day, every day for 12 weeks. Two capsules per day are equal to approximately a ½ teaspoon or 18 kilocalories. It does not matter if they choose to take each capsule at the same time or at different times during the day. To help remind participants to take their supplements each day, they will receive a 7 day pill organizer and a daily check list. At this session, participants will receive a second 3-day diet and supplement diary that is to be completed one week before the final session. At the end of the second session, the researcher will schedule the final session with the participant.

The third and final session will take place 12 weeks after the initial session. Measurements taken during the final session will be height, weight, BMI, percent body fat, and blood pressure. The participant will be asked to complete a food frequency questionnaire identical the questionnaire filled out during the first session with the researcher. Participant will be asked to return their 3-day diet and supplement diary, daily check list, pill organizer, 2 pill bottles, and any unused supplements. After completion of the study the participant will receive a $20 Target gift card at this session.

A potential risk of this study includes loss of confidentiality. Confidentiality will be maintained by the use of code numbers rather than names on data containing documents. Digital data analyses will be done using only code numbers and not identifiable data. Data recorded on paper containing identifiable and non-identifiable participant information (consent forms, data collection forms, 3-day diet and supplement diaries, physical activity questionnaires, food frequency questionnaires, and participant daily checklists) will be kept in a locked cabinet in Room 10132B in the Texas Woman's University, Houston Office of Research.

Another potential risk of this study may be that the participant's normal schedule is disrupted by coming to the Texas Woman's University, Houston campus. To minimize this risk, sessions will be scheduled with the researcher in advance Monday through Friday, from 8 a.m. to 5 p.m. to accommodate the participant's schedule.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77030
        • Texas Woman's University, Institute of Health Sciences- Houston Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Read, speak, and write English
  • Premenopausal

Exclusion Criteria:

  • Consuming estrogen supplements
  • Taking hypertensive blood pressure medication
  • Consuming pumpkin seed oil supplements
  • Consuming pumpkin seeds more than once a month
  • Wheat allergy or gluten intolerance
  • Blood pressure > 140/90 mmHg

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: Wheat Germ Oil
Participants will be instructed to consume 2 wheat germ oil capsules ,2g, per day for 12 weeks.
2 grams per day, everyday for 12 weeks.
EXPERIMENTAL: Pumpkin Seed Oil
Participants will be instructed to consume 2 pumpkin seed oil capsules ,2g, per day for 12 weeks
2 grams per day, everyday for 12 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change From Baseline Systolic Blood Pressure at 12 weeks
Time Frame: Baseline, 12 weeks
Baseline, 12 weeks
Change From Baseline Diastolic Blood Pressure at 12 weeks
Time Frame: Baseline, 12 weeks
Baseline, 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Mass Index (BMI)
Time Frame: Baseline
BMI is an important measurement to record because an increase in weight may be accompanied by an increase in blood pressure.
Baseline
Percent Body Fat
Time Frame: Baseline
Percent body fat is an important measurement to record because an increase in body fat may be accompanied by an increase in blood pressure.
Baseline
Nutrient content of diet
Time Frame: Baseline
Participants will be given instructions on how to keep a 3-day diet and supplement diary. A booklet will be provided to help them record their diet for two nonconsecutive week days and one weekend day. Diet will then be analyzed using Minnesota Nutrition Data System for calories, carbohydrate, protein, fat, vitamins, minerals, and phytoestrogen content.
Baseline
Phytoestrogen content of diet
Time Frame: Baseline
A food frequency questionnaire will be given to each participants to assess the phytoestrogen content of her diet.
Baseline
Activity Level
Time Frame: Baseline
The purpose of the physical activity questionnaire is to establish each participant's activity level because physical activity level may have an effect on blood pressure.
Baseline
Body Mass Index (BMI)
Time Frame: 12 weeks
BMI is an important measurement to record because an increase in weight may be accompanied by an increase in blood pressure.
12 weeks
Percent Body Fat
Time Frame: 12 weeks
Percent body fat is an important measurement to record because an increase in body fat may be accompanied by an increase in blood pressure.
12 weeks
Nutrient content of diet
Time Frame: 12 weeks
Participants will be given instructions on how to keep a 3-day diet and supplement diary. A booklet will be provided to help them record their diet for two nonconsecutive week days and one weekend day. Diet will then be analyzed using Minnesota Nutrition Data System for calories, carbohydrate, protein, fat, vitamins, minerals, and phytoestrogen content.
12 weeks
Phytoestrogen content of diet
Time Frame: 12 weeks
A food frequency questionnaire will be given to each participants to assess the phytoestrogen content of her diet.
12 weeks
Activity Level
Time Frame: 12 weeks
The purpose of the physical activity questionnaire is to establish each participant's activity level because physical activity level may have an effect on blood pressure.
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Samantha L Caudill, BS, Texas Woman's University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (ACTUAL)

May 1, 2015

Study Completion (ACTUAL)

May 1, 2015

Study Registration Dates

First Submitted

April 15, 2014

First Submitted That Met QC Criteria

April 17, 2014

First Posted (ESTIMATE)

April 21, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

June 18, 2015

Last Update Submitted That Met QC Criteria

June 17, 2015

Last Verified

December 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • 17411a

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Pressure

Clinical Trials on Wheat Germ Oil

3
Subscribe